Parkisonism induced by high‐dose cytosine arabinoside
Identifieur interne : 003A39 ( Istex/Corpus ); précédent : 003A38; suivant : 003A40Parkisonism induced by high‐dose cytosine arabinoside
Auteurs : Luque ; John B. Selhorst ; Paul PetruskaSource :
- Movement Disorders [ 0885-3185 ] ; 1987.
English descriptors
Abstract
We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.
Url:
DOI: 10.1002/mds.870020309
Links to Exploration step
ISTEX:AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkisonism induced by high‐dose cytosine arabinoside</title>
<author><name sortKey="Luque" sort="Luque" uniqKey="Luque" last="Luque">Luque</name>
<affiliation><mods:affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Selhorst, John B" sort="Selhorst, John B" uniqKey="Selhorst J" first="John B." last="Selhorst">John B. Selhorst</name>
<affiliation><mods:affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Petruska, Paul" sort="Petruska, Paul" uniqKey="Petruska P" first="Paul" last="Petruska">Paul Petruska</name>
<affiliation><mods:affiliation>Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88</idno>
<date when="1987" year="1987">1987</date>
<idno type="doi">10.1002/mds.870020309</idno>
<idno type="url">https://api.istex.fr/document/AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003A39</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parkisonism induced by high‐dose cytosine arabinoside</title>
<author><name sortKey="Luque" sort="Luque" uniqKey="Luque" last="Luque">Luque</name>
<affiliation><mods:affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Selhorst, John B" sort="Selhorst, John B" uniqKey="Selhorst J" first="John B." last="Selhorst">John B. Selhorst</name>
<affiliation><mods:affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Petruska, Paul" sort="Petruska, Paul" uniqKey="Petruska P" first="Paul" last="Petruska">Paul Petruska</name>
<affiliation><mods:affiliation>Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1987">1987</date>
<biblScope unit="vol">2</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="219">219</biblScope>
<biblScope unit="page" to="222">222</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88</idno>
<idno type="DOI">10.1002/mds.870020309</idno>
<idno type="ArticleID">MDS870020309</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cytosine arabinoside</term>
<term>Myelogenous leukemia</term>
<term>Parkinsonism</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>Dr. Luque</name>
<affiliations><json:string>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</json:string>
</affiliations>
</json:item>
<json:item><name>John B. Selhorst</name>
<affiliations><json:string>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</json:string>
</affiliations>
</json:item>
<json:item><name>Paul Petruska</name>
<affiliations><json:string>Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>Parkinsonism</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Cytosine arabinoside</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Myelogenous leukemia</value>
</json:item>
</subject>
<language><json:string>eng</json:string>
</language>
<abstract>We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.</abstract>
<qualityIndicators><score>2.213</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>504 x 737.759 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>356</abstractCharCount>
<pdfWordCount>1601</pdfWordCount>
<pdfCharCount>10064</pdfCharCount>
<pdfPageCount>4</pdfPageCount>
<abstractWordCount>51</abstractWordCount>
</qualityIndicators>
<title>Parkisonism induced by high‐dose cytosine arabinoside</title>
<genre><json:string>Serial article</json:string>
</genre>
<host><volume>2</volume>
<pages><total>4</total>
<last>222</last>
<first>219</first>
</pages>
<issn><json:string>0885-3185</json:string>
</issn>
<issue>3</issue>
<subject><json:item><value>Case Report</value>
</json:item>
</subject>
<genre></genre>
<language><json:string>unknown</json:string>
</language>
<title>Movement Disorders</title>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>1987</publicationDate>
<copyrightDate>1987</copyrightDate>
<doi><json:string>10.1002/mds.870020309</json:string>
</doi>
<id>AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88</id>
<fulltext><json:item><original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88/fulltext/pdf</uri>
</json:item>
<json:item><original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Parkisonism induced by high‐dose cytosine arabinoside</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability><p>Wiley Subscription Services, Inc., A Wiley Company</p>
</availability>
<date>1987</date>
</publicationStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Parkisonism induced by high‐dose cytosine arabinoside</title>
<author><persName><surname>Luque</surname>
<roleName type="degree">Dr.</roleName>
</persName>
<note type="correspondence"><p>Correspondence: Department of Neurology, Saint Louis University, 3660 Vista, # 303, St. Louis, MO 63110</p>
</note>
<affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</affiliation>
</author>
<author><persName><forename type="first">John B.</forename>
<surname>Selhorst</surname>
</persName>
<affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</affiliation>
</author>
<author><persName><forename type="first">Paul</forename>
<surname>Petruska</surname>
</persName>
<affiliation>Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri</affiliation>
</author>
</analytic>
<monogr><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1987"></date>
<biblScope unit="vol">2</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="219">219</biblScope>
<biblScope unit="page" to="222">222</biblScope>
</imprint>
</monogr>
<idno type="istex">AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88</idno>
<idno type="DOI">10.1002/mds.870020309</idno>
<idno type="ArticleID">MDS870020309</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1987</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.</p>
</abstract>
<textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head>
<item><term>Parkinsonism</term>
</item>
<item><term>Cytosine arabinoside</term>
</item>
<item><term>Myelogenous leukemia</term>
</item>
</list>
</keywords>
</textClass>
<textClass><keywords scheme="Journal Subject"><list><head>Article category</head>
<item><term>Case Report</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="1987">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="tocForm">Movement Disorders</title>
<title type="subtitle">Official Journal of the Movement Disorder Society</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="30"><doi origin="wiley" registered="yes">10.1002/mds.v2:3</doi>
<numberingGroup><numbering type="journalVolume" number="2">2</numbering>
<numbering type="journalIssue">3</numbering>
</numberingGroup>
<coverDate startDate="1987">1987</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="caseStudy" position="9" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870020309</doi>
<idGroup><id type="unit" value="MDS870020309"></id>
</idGroup>
<countGroup><count type="pageTotal" number="4"></count>
</countGroup>
<titleGroup><title type="articleCategory">Case Report</title>
<title type="tocHeading1">Case Reports</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 1987 Movement Disorder Society</copyright>
<eventGroup><event type="firstOnline" date="2004-10-12"></event>
<event type="publishedOnlineFinalForm" date="2004-10-12"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">219</numbering>
<numbering type="pageLast">222</numbering>
</numberingGroup>
<correspondenceTo>Department of Neurology, Saint Louis University, 3660 Vista, # 303, St. Louis, MO 63110</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870020309.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="0"></count>
<count type="referenceTotal" number="17"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">Parkisonism induced by high‐dose cytosine arabinoside</title>
<title type="short" xml:lang="en">PARKINSONISM INDUCED BY CYTOSINE ARABINOSIDE</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics>
<givenNames>F. Antonio</givenNames>
<familyName>Luque</familyName>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>John B.</givenNames>
<familyName>Selhorst</familyName>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Paul</givenNames>
<familyName>Petruska</familyName>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinsonism</keyword>
<keyword xml:id="kwd2">Cytosine arabinoside</keyword>
<keyword xml:id="kwd3">Myelogenous leukemia</keyword>
</keywordGroup>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Parkisonism induced by high‐dose cytosine arabinoside</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>PARKINSONISM INDUCED BY CYTOSINE ARABINOSIDE</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Parkisonism induced by high‐dose cytosine arabinoside</title>
</titleInfo>
<name type="personal"><namePart type="termsOfAddress">Dr.</namePart>
<namePart type="family">Luque</namePart>
<affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</affiliation>
<description>Correspondence: Department of Neurology, Saint Louis University, 3660 Vista, # 303, St. Louis, MO 63110</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">John B.</namePart>
<namePart type="family">Selhorst</namePart>
<affiliation>Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Paul</namePart>
<namePart type="family">Petruska</namePart>
<affiliation>Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="originalCategForm">caseStudy</genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">1987</dateIssued>
<copyrightDate encoding="w3cdtf">1987</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="references">17</extent>
</physicalDescription>
<abstract lang="en">We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.</abstract>
<subject lang="en"><genre>Keywords</genre>
<topic>Parkinsonism</topic>
<topic>Cytosine arabinoside</topic>
<topic>Myelogenous leukemia</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
<subTitle>Official Journal of the Movement Disorder Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<subject><genre>article category</genre>
<topic>Case Report</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>1987</date>
<detail type="volume"><caption>vol.</caption>
<number>2</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>219</start>
<end>222</end>
<total>4</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88</identifier>
<identifier type="DOI">10.1002/mds.870020309</identifier>
<identifier type="ArticleID">MDS870020309</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 1987 Movement Disorder Society</accessCondition>
<recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003A39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:AEFA37C4A82B19515DCBBCBD0C7B6B08AF97FE88 |texte= Parkisonism induced by high‐dose cytosine arabinoside }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |